Pavel D. Hrdina

4.5k total citations · 1 hit paper
88 papers, 3.5k citations indexed

About

Pavel D. Hrdina is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Pavel D. Hrdina has authored 88 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cellular and Molecular Neuroscience, 37 papers in Molecular Biology and 21 papers in Pharmacology. Recurrent topics in Pavel D. Hrdina's work include Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (27 papers) and Treatment of Major Depression (17 papers). Pavel D. Hrdina is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (27 papers) and Treatment of Major Depression (17 papers). Pavel D. Hrdina collaborates with scholars based in Canada, United States and Hungary. Pavel D. Hrdina's co-authors include David Bakish, Lisheng Du, Radhey L. Singhal, Y.D. Lapierre, Miklós Palkovits, George M. Ling, Péter Sótonyi, Arun Ravindran, Jerzy Chudzik and Gábor Faludi and has published in prestigious journals such as Journal of Neuroscience, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Pavel D. Hrdina

88 papers receiving 3.4k citations

Hit Papers

Impaired Repression at a 5-Hydroxytryptamine 1A Receptor ... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavel D. Hrdina Canada 32 1.9k 1.1k 647 613 519 88 3.5k
D. Eccleston United Kingdom 33 1.4k 0.8× 661 0.6× 949 1.5× 573 0.9× 296 0.6× 94 3.5k
Moshe Rehavi Israel 34 1.6k 0.9× 1.3k 1.2× 598 0.9× 458 0.7× 328 0.6× 123 3.8k
Farouk Karoum United States 36 2.3k 1.2× 1.3k 1.2× 767 1.2× 513 0.8× 185 0.4× 130 4.6k
N. Brunello Italy 39 1.8k 1.0× 1.2k 1.1× 710 1.1× 617 1.0× 439 0.8× 139 4.6k
Philip A. Berger United States 31 956 0.5× 565 0.5× 863 1.3× 452 0.7× 273 0.5× 93 3.0k
Kenneth W. Perry United States 39 3.3k 1.8× 1.7k 1.6× 734 1.1× 973 1.6× 252 0.5× 115 5.2k
John H. Kehne United States 33 1.9k 1.0× 903 0.8× 504 0.8× 362 0.6× 434 0.8× 68 3.2k
Malcolm B. Bowers United States 36 1.6k 0.9× 558 0.5× 1.9k 2.9× 712 1.2× 675 1.3× 136 4.2k
Jerzy Vetulani Poland 31 2.2k 1.2× 1.4k 1.3× 538 0.8× 757 1.2× 138 0.3× 106 3.7k
Morris A. Lipton United States 30 2.0k 1.1× 1.2k 1.1× 532 0.8× 571 0.9× 214 0.4× 68 3.9k

Countries citing papers authored by Pavel D. Hrdina

Since Specialization
Citations

This map shows the geographic impact of Pavel D. Hrdina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel D. Hrdina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel D. Hrdina more than expected).

Fields of papers citing papers by Pavel D. Hrdina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel D. Hrdina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel D. Hrdina. The network helps show where Pavel D. Hrdina may publish in the future.

Co-authorship network of co-authors of Pavel D. Hrdina

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel D. Hrdina. A scholar is included among the top collaborators of Pavel D. Hrdina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel D. Hrdina. Pavel D. Hrdina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Lisheng, David Bakish, Arun Ravindran, & Pavel D. Hrdina. (2004). MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. Neuroreport. 15(13). 2097–2101. 51 indexed citations
2.
Du, Lisheng, Gábor Faludi, Miklós Palkovits, et al.. (2002). High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport. 13(9). 1195–1198. 91 indexed citations
3.
Du, Lisheng, David Bakish, & Pavel D. Hrdina. (2001). Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. Journal of Affective Disorders. 65(1). 37–44. 35 indexed citations
4.
Du, Lisheng, David Bakish, Y.D. Lapierre, Arun Ravindran, & Pavel D. Hrdina. (2000). Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics. 96(1). 56–60. 177 indexed citations
5.
Alda, Martin & Pavel D. Hrdina. (2000). Distribution of platelet 5-HT2A receptor densities in suicidal and non-suicidal depressives and control subjects. Psychiatry Research. 94(3). 273–277. 14 indexed citations
6.
Du, Lisheng, et al.. (1999). Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Research. 87(1). 1–5. 51 indexed citations
7.
Du, Lisheng, Gábor Faludi, Miklós Palkovits, et al.. (1999). Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biological Psychiatry. 46(2). 196–201. 142 indexed citations
8.
Hrdina, Pavel D.. (1996). Basic Neurochemistry : Molecular, Cellular and Medical Aspects. Journal of Psychiatry and Neuroscience. 21(5). 352–353. 83 indexed citations
9.
Chudzik, Jerzy, et al.. (1995). Synthesis and characterization of an aryl-azidoparoxetine. Biochemical Pharmacology. 50(8). 1211–1215. 3 indexed citations
10.
11.
Browne, Michael W., Y.D. Lapierre, Pavel D. Hrdina, & Eva K. Horn. (1990). Lithium as an Adjunct in the Treatment of Major Depression. International Clinical Psychopharmacology. 5(2). 103–110. 20 indexed citations
12.
Hrdina, Pavel D., et al.. (1988). Antidepressant Plasma Levels and Clinical Response in Depressed Patients Treated with Oxaprotiline and Doxepin. International Clinical Psychopharmacology. 3(3). 205–214. 2 indexed citations
13.
Hrdina, Pavel D.. (1988). Inhibition of sodium-dependent [3H]imipramine binding in rat brain by serotonin and serotonin uptake inhibitors. European Journal of Pharmacology. 148(2). 279–282. 12 indexed citations
14.
Hrdina, Pavel D., et al.. (1984). The effects of low-level lead exposure in developing rats: changes in circadian locomotor activity and hippocampal noradrenaline turnover. Canadian Journal of Physiology and Pharmacology. 62(4). 430–435. 13 indexed citations
15.
Hrdina, Pavel D., et al.. (1983). Mianserin kinetics in depressed patients. Clinical Pharmacology & Therapeutics. 33(6). 757–762. 10 indexed citations
16.
Hrdina, Pavel D., Bruce A. Pappas, Robert J. Bialik, & Catherine L. Ryan. (1982). Regulation of [3H]imipramine binding sites in rat brain regions: Effect of neonatal 5, 7-dihydroxytryptamine treatment. European Journal of Pharmacology. 83(3-4). 343–344. 11 indexed citations
17.
Hrdina, Pavel D. & Y.D. Lapierre. (1981). Clinical response, plasma levels and pharmacokinetics of desiramine in depressed in-patients. Progress in Neuro-Psychopharmacology. 4(6). 591–600. 12 indexed citations
18.
Hrdina, Pavel D.. (1981). Neuroendocrine Regulation and Altered Behaviour. Europe PMC (PubMed Central). 9 indexed citations
19.
Hrdina, Pavel D., Radhey L. Singhal, & George M. Ling. (1975). DDT and Related Chlorinated Hydrocarbon Insecticides: Pharmacological Basis of Their Toxicity in Mammals. Advances in pharmacology. 12(0). 31–88. 34 indexed citations
20.
Kacew, Sam, Radhey L. Singhal, Pavel D. Hrdina, & George M. Ling. (1972). CHANGES IN KIDNEY CORTEX GLUCONEOGENIC ENZYMES INDUCED BY 1,1,1-TRICHLORO-2,2-BIS-(p-CHLOROPHENYL) ETHANE (DDT). Journal of Pharmacology and Experimental Therapeutics. 181(2). 234–243. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026